# MAGnesium Adjunction in Alcohol Withdrawal Syndrome: a Multicenter Assessment (MAGMA)

> **NCT03033823** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 105 (actual)

## Conditions studied

- Alcohol Withdrawal Syndrome

## Interventions

- **DRUG:** Magnesium
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03033823
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-16
- **Primary completion:** 2020-10-23
- **Final completion:** 2020-10-23
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2021-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03033823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03033823, "MAGnesium Adjunction in Alcohol Withdrawal Syndrome: a Multicenter Assessment (MAGMA)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03033823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*